Kenneth Gordon to Recurrence
This is a "connection" page, showing publications Kenneth Gordon has written about Recurrence.
Connection Strength
0.304
-
Guselkumab Efficacy after Withdrawal Is Associated with Suppression of Serum IL-23-Regulated IL-17 and IL-22 in Psoriasis: VOYAGE 2 Study. J Invest Dermatol. 2019 12; 139(12):2437-2446.e1.
Score: 0.140
-
Adalimumab retreatment successfully restores clinical response and health-related quality of life in patients with moderate to severe psoriasis who undergo therapy interruption. J Eur Acad Dermatol Venereol. 2015 Apr; 29(4):767-76.
Score: 0.101
-
Duration of remission of biologic agents for chronic plaque psoriasis. J Drugs Dermatol. 2007 Dec; 6(12):1205-12.
Score: 0.063